An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy.

Trial Profile

An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 14 Mar 2015

At a glance

  • Drugs Grass pollen allergy immunotherapy (Primary)
  • Indications Allergic rhinoconjunctivitis; Grass pollen hypersensitivity
  • Focus Adverse reactions; Registrational
  • Sponsors ALK-Abello
  • Most Recent Events

    • 24 Apr 2012 Actual patient number (198) added as reported by ClinicalTrials.gov.
    • 24 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Apr 2012 Actual end date (Apr 2012) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top